Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Recruiting 6 Terminated 5 Unknown 2 Withdrawn 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 6 Leukemia, Myeloid, Acute 3 Carcinoma, Renal Cell 3 Ovarian Cancer Metastatic 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Lymphoma, B-Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Kidney Neoplasms 1 Invasive Bladder Cancer Stage IV 1 Hormone Refractory Prostate Cancer 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Paclitaxel 28 Trastuzumab 22 Cyclophosphamide 21 Doxorubicin 14 Docetaxel 14 Carboplatin 11 exemestane 10 Radiotherapy 10 Letrozole 10 Capecitabine 10 pembrolizumab 8 Lapatinib 8 Fulvestrant 8 Neoadjuvant Therapy 6 Goserelin 6 Bevacizumab 6 Anastrozole 6 pertuzumab 5 palbociclib 5 eribulin 5 abemaciclib 5 Therapeutics 5 Magnetic Resonance Spectroscopy 5 Epirubicin 5 Chemotherapy, Adjuvant 5 Aromatase Inhibitors 5 tucatinib 4 Vinorelbine 4 Taxes 4 Tamoxifen 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Breast Neoplasms × Interleukin-2 × Clear all

NCT00935558 2012-05-31

Dendritic Cell Based Therapy for Breast Cancer Patients

Herlev Hospital

Phase 2 Withdrawn

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡